Related Experiment Video
Updated: Jan 17, 2026
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Osteoprotegerin as a Potential Biomarker for Breast Cancer: A Study of Its Relationship with Bone Health, vitamin D,
Shahad A Jarallah1, Ali Abdul Rasool Hussein2, Ola H Fadhil1
1Iraqi Center for Cancer and Medical Genetics Research, Mustansiriyah University, Baghdad, Iraq.
Background:
Breast cancer continues to be a significant global health issue and is associated with various biological indicators, including osteoprotegerin (OPG), a glycoprotein involved in bone metabolism, tumor progression, and immunological modulation. This study examined the potential of OPG as a biomarker for breast cancer and its correlation with bone health, vitamin D levels, and calcium concentrations.
Objectives:
To quantify serum OPG levels in breast cancer patients and assess its viability as a diagnostic biomarker. In addition, to evaluate vitamin D levels due to their established correlation with an increased cancer risk in cases of deficiency. The study also examined parathyroid hormone (PTH) and calcium levels in breast cancer patients.
Methods:
Blood samples were obtained from female volunteers at the Oncology Teaching Hospital, Medical City, Baghdad, Iraq (September 2023 - February 2024). The study comprised three cohorts: healthy controls (G1, n=40), newly diagnosed breast cancer patients (G2, n=45), and patients undergoing chemotherapy (G3, n=45). Serum concentrations of OPG, vitamin D, PTH, and calcium were quantified using ELISA methodologies.
Results:
No statistically significant variations in OPG levels were observed between the control and patient groups, indicating minimal bone resorption during the early stages of breast cancer. Vitamin D levels were markedly reduced in G2 compared with the control group, while G3 showed a modest increase in vitamin D levels attributable to supplementation. Increased PTH levels were observed in breast cancer patients, supporting prior research linking elevated PTH with increased cancer risk. No notable differences were found in serum calcium levels among the groups.
Conclusion:
Vitamin D and PTH levels are crucial in early-stage breast cancer development, underscoring the need for monitoring these factors and questioning the diagnostic efficacy of OPG alone.
More Related Videos
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Related Concept Videos
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:40Bone Remodeling
01:21Skeleton and Calcium Homeostasis
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Osteoclasts in Bone Remodeling
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...